Common chemicals acting together may be carcinogenic to humans
the ONA take:
Common chemicals not considered to be carcinogenic to humans at low doses may act together to increase cancer risk, according a 3-year investigation conducted by a task force comprised of nearly 200 researchers from 28 countries.
Of the 85 chemicals studied, 50 were found to disrupt normal cell function in ways that are known to be associated with early signs of cancer.
Chemicals studied included bisphenol A (BPA), a chemical used in plastics, rotenone, an insecticide, paraquat, a herbicide, triclosan, an antibacterial agent, and EDTA, a metal-ion-binding compound used in manufacturing and medicine.
"Our findings also suggest these molecules may be acting in synergy to increase cancer activity," said William Bisson, an assistant professor and cancer researcher at OSU and a team leader on the study.
EDTA alone does not cause gene mutations, but when exposed to that and something else that is mutagenic, the effect of DNA repair disruption is enhanced.
The findings suggest that more research is warranted to evaluate early exposure to these common chemicals and how those chemicals affect the early stages of cancer development.
Common chemicals not considered to be carcinogenic to humans at low doses may act together to increase cancer risk.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Olanzapine Efficacious for Treatment of Breakthrough CINV
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Atypical Teratoid/rhabdoid Tumors: Challenges and Search for Solutions
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|